Please login to the form below

Not currently logged in
Email:
Password:

Orexo hires new CEO as Biolipox acquisition closes

The board of directors of Swedish pharmaceutical company Orexo appoints Torbjoern Bjerke as new CEO of the company

The board of directors of Swedish pharmaceutical company Orexo has appointed Torbjoern Bjerke as new CEO of the company.

The appointment was announced at the same time as Orexo revealed it had finally acquired Biolipox.

Orexo has acquired all shares and warrants in Biolipox through payment consisting of 7,630,895 new shares in Orexo and 926,000 warrants allowing subscription for 926,000 new shares in Orexo.

Bjerke was previously CEO in Biolipox. As previously announced, Zsolt Lavotha, Orexo's former CEO, will leave his post and serve as Senior Advisor to Orexo's board.

The board of directors of Orexo has also prepared a prospectus regarding listing of shares in Orexo in connection with the acquisition of Biolipox.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Article
How will COVID-19 affect uptake of vaccinations against other diseases?...
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
Podcast
Living With Chronic Illness (Series one)...

Infographics